Ouyang, M., White, E. E., Ren, H., Guo, Q., Zhang, I., Gao, H., . . . Badie, B. (2016). Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model. PloS one, 11(2), e0148139. https://doi.org/10.1371/journal.pone.0148139
Chicago Style (17th ed.) CitationOuyang, Mao, et al. "Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model." PloS One 11, no. 2 (2016): e0148139. https://doi.org/10.1371/journal.pone.0148139.
MLA (9th ed.) CitationOuyang, Mao, et al. "Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model." PloS One, vol. 11, no. 2, 2016, p. e0148139, https://doi.org/10.1371/journal.pone.0148139.